CURA, ANDREA CECILIA; ZUCHUAT, JESICA ITATÍ; TRIBBIA, LILIANA TERESITA; TARAVINI, IRENE RITA ELOISA; DECCO, OSCAR ALFREDO

Sandblasted, acid etched and UV irradiated titanium surface for dental implants: In vitro and in vivo analysis

Materialia; Año: 2022 vol. 21

SCHENK M.; FERRARIO M.; SCHMALKO M.; RIVERO RC.; TARAVINI IRE.; GUERRERO S.

Development of extracts obtained from yerba mate leaves with different industrial processing steps. Antimicrobial capacity, antioxidant properties and induced damage

JOURNAL OF FOOD PROCESSING AND PRESERVATION; Lugar: Londres; Año: 2021

GOMEZ, G.; ESCANDE, M.V.; SUAREZ, L.M.; RELA, L.; BELFORTE, J.E.; MORATALLA, R.; MURER, M.G.; GERSHANIK, O.S.; TARAVINI, I.R.E.

Changes in Dendritic Spine Density and Inhibitory Perisomatic Connectivity onto Medium Spiny Neurons in l-Dopa-Induced Dyskinesia

MOLECULAR NEUROBIOLOGY; Año: 2019

BERNARDI, ALEJANDRA; BALLESTERO, PEDRO; SCHENK, MARCELA; FERRARIO, MARIANA; GÓMEZ, GIMENA; RIVERO, ROY; AVALE, ELENA; TARAVINI, IRENE; GERSHANIK, OSCAR; GUERRERO, SANDRA; FERRARIO, JUAN E.

Yerba mate (Ilex paraguariensis) favors survival and growth of dopaminergic neurons in culture

MOVEMENT DISORDERS; Año: 2019 vol. 34 p. 920 - 922

GOMEZ, GIMENA; SABORIDO, MARIANO D.; ALEJANDRA BERNARDI, M.; GERSHANIK, OSCAR S.; TARAVINI, IRENE R.; FERRARIO, JUAN E.

Regulation of Pleiotrophin and Fyn in the striatum of rats undergoing L-DOPA-induced dyskinesia

NEUROSCIENCE LETTERS; Año: 2018 vol. 666 p. 5 - 10

GOMEZ G.; BERNARDI MA; SANZ BLASCO S; BORDONE M; TARAVINI IRE; FERRARIO JE

Enfermedad de Parkinson y disquinesias: comprender y disecar los mecanismos moleculares para racionalizar el diseño y uso de fármacos

Ciencia e Investigación; Lugar: Ciudad Autónoma de Buenos Aires; Año: 2017 p. 19 - 26

SANZ-BLASCO, SARA; BORDONE, MELINA P.; DAMIANICH, ANA; GOMEZ, GIMENA; BERNARDI, M. ALEJANDRA; ISAJA, LUCIANA; TARAVINI, IRENE R.; HANGER, DIANE P.; AVALE, M. ELENA; GERSHANIK, OSCAR S.; FERRARIO, JUAN E.

The Kinase Fyn As a Novel Intermediate in l-DOPA-Induced Dyskinesia in Parkinson’s Disease

MOLECULAR NEUROBIOLOGY; Año: 2017 p. 1 - 12

ESCANDE M; TARAVINI IR; ZOLD CL; BELFORTE J; MURER MG

Loss of Homeostasis in the Direct Pathway in a Mouse Model of Asymptomatic Parkinson?s Disease

JOURNAL OF NEUROSCIENCE; Lugar: Washington; Año: 2016 vol. 36 p. 5686 - 5698

TARAVINI IR; LARRAMENDY C; GOMEZ G.; SABORIDO MD; SPAANS F; FRESNO C; GONZALEZ G; FERNANDEZ EA; MURER MG; GERSHANIK OS

Contrasting gene expression patterns induced by levodopa and pramipexole treatments in the rat model of Parkinson's disease

NEUROPHARMACOLOGY; Lugar: Amsterdam; Año: 2016 vol. 101 p. 576 - 589

TUBERT C; TARAVINI IR; FLORES-BARRERA E; SÁNCHEZ GM; PROST MA; AVALE ME; TSENG KY; RELA L; MURER MG

Decrease of a Current Mediated by Kv1.3 Channels Causes Striatal Cholinergic Interneuron Hyperexcitability in Experimental Parkinsonism.

Cell Reports; Lugar: Berlin; Año: 2016 vol. 16 p. 2749 - 2762

BRAZ B; GALIÑANES G; TARAVINI IR; BELFORTE J; MURER MG

Altered Corticostriatal Connectivity and Exploration-Exploitation Imbalance Emerge as Intermediate Phenotypes for a Neonatal Dopamine Dysfunction

NEUROPSYCHOPHARMACOLOGY; Lugar: Londres; Año: 2015

SUÁREZ LM; SOLIS O; CARAMÉS JM; TARAVINI IR; MURER MG; MORATALLA R

L-DOPA Treatment Selectively Restores Spine Density in Dopamine Receptor D2-Expressing Projection Neurons in Dyskinetic Mice

BIOLOGICAL PSYCHIATRY; Lugar: Amsterdam; Año: 2014 vol. 75 p. 711 - 722

PEDRÓN VT; TARAVINI IR; INDUNI AS; BALERIO GN

Baclofen did not modify sexually dimorphic c-Fos expression during morphine withdrawal syndrome.

SYNAPSE; Lugar: New York; Año: 2013 vol. 67 p. 118 - 126

RAINERI M; PESKIN V; GOITIA B; TARAVINI IR; GIORGERI S; URBANO FJ; BISAGNO V

Attenuated methamphetamine induced neurotoxicity by modafinil administration in mice.

SYNAPSE; Lugar: Nueva York; Año: 2011 vol. 65 p. 1087 - 1098

TARAVINI IR; CHERTOFF M; CAFFERATA E; COURTY J; MURER MG; PITOSSI F; GERSHANIK OS

Pleiotrophin over-expression provides trophic support to dopaminergic neurons in parkinsonian rats.

MOLECULAR NEURODEGENERATION; Lugar: Londres; Año: 2011 vol. 6 p. 40 - 51

GREGORIO L. GALIÑANES; IRENE R. E. TARAVINI; M. GUSTAVO MURER

Cortical control of striatal activity in a mouse model of attention deficit/hyperactivity disorder

JOURNAL OF NEUROSCIENCE; Lugar: United States; Año: 2009 vol. 29 p. 2496 - 2509

LARRAMENDY C; TARAVINI IR; SABORIDO MD; FERRARIO JE; MURER MG; GERSHANIK OS

Cabergoline and pramipexole fail to modify already established dyskinesias in an animal model of parkinsonism.

BEHAVIOURAL BRAIN RESEARCH; Lugar: Netherlands; Año: 2008

DELFINO MA; KALISCH R; CZISCH M; LARRAMENDY C; RICATTI J; TARAVINI IR; TRENKWALDER C; MURER MG; AUER DP; GERSHANIK OS

Mapping the effects of three dopamine agonists with different dyskinetogenic potential and receptor selectivity using pharmacological functional magnetic resonance imaging.

NEUROPSYCHOPHARMACOLOGY; Lugar: United States; Año: 2007 vol. 32 p. 1911 - 1921

TARAVINI IR; FERRARIO JE; DELBE J; GINESTET L; DEBEIR T; COURTY J; MURER MG; GERSHANIK OS; RAISMAN-VOZARI R

Immunodetection of heparin-binding growth associated molecule (pleiotrophin) in striatal interneurons.

BRAIN RESEARCH; Lugar: Netherlands; Año: 2005 vol. 1066 p. 196 - 200

DELFINO MA; STEFANO AV; FERRARIO JE; TARAVINI IR; MURER MG; GERSHANIK OS

Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias.

BEHAVIOURAL BRAIN RESEARCH; Lugar: Netherlands; Año: 2004 vol. 152 p. 297 - 306

FERRARIO JE; TARAVINI IR; MOURLEVAT S; STEFANO A; DELFINO MA; RAISMAN-VOZARI R; MURER MG; RUBERG M; GERSHANIK O

Differential gene expression induced by chronic levodopa treatment in the striatum of rats with lesions of the nigrostriatal system.

JOURNAL OF NEUROCHEMISTRY; Lugar: England; Año: 2004 vol. 90 p. 1348 - 1358